No Data
Dingdong Health (09886.HK) released its 2024 Earnings Reports: Annual revenue reached 4.669 billion yuan.
Recently, the instant health home service company Dingdang Health (stock code: 09886.HK) released its performance report for the year 2024. The Earnings Reports show that the company's annual revenue reached 4.669 billion yuan, with a record gross margin of 1.538 billion yuan, and a gross margin of 32.9%, up by 1.8 percentage points year-on-year. Through supply chain optimization, digital operation, and cost control, the adjusted loss for the year was reduced by 32%, highlighting the results of cost reduction and efficiency improvement and demonstrating the company's strategic resilience amid industry transformation. Despite fierce market competition, the company's cash flow remains ample, laying a solid foundation for subsequent strategic investments. Global Strategy.
Express News | Dingdang Health Technology Group Ltd - Subscribes to Structured Deposit Product Worth RMB80 Million
DINGDANG HEALTH: ANNUAL REPORT 2024
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Trending Industry Today: ALI HEALTH Leads Gains In Digital Health Stocks
Trending Industry Today: DINGDANG HEALTH Leads Losses In Digital Health Stocks
